These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27287466)

  • 1. Updates on Therapeutic Strategies Against Candida (and Aspergillus) Biofilm Related Infections.
    Muakkassa FK; Ghannoum M
    Adv Exp Med Biol; 2016; 931():95-103. PubMed ID: 27287466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of a novel compound, Mul-1867, against clinically significant fungi Candida spp. and Aspergillus spp.
    Tetz G; Cynamon M; Hendricks G; Vikina D; Tetz V
    Int J Antimicrob Agents; 2017 Jul; 50(1):47-54. PubMed ID: 28457835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspergillus Biofilms in Human Disease.
    Williams C; Rajendran R; Ramage G
    Adv Exp Med Biol; 2016; 931():1-11. PubMed ID: 27271678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs.
    Nett JE; R Andes D
    Microbiol Spectr; 2015 Jun; 3(3):E30. PubMed ID: 26397003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on antifungal resistance in Aspergillus and Candida.
    Arendrup MC
    Clin Microbiol Infect; 2014 Jun; 20 Suppl 6():42-8. PubMed ID: 24372701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clioquinol is a promising preventive morphological switching compound in the treatment of Candida infections linked to the use of intrauterine devices.
    Pippi B; Machado GDRM; Bergamo VZ; Alves RJ; Andrade SF; Fuentefria AM
    J Med Microbiol; 2018 Nov; 67(11):1655-1663. PubMed ID: 30256190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioluminescence Imaging to Study Mature Biofilm Formation by Candida spp. and Antifungal Activity In Vitro and In Vivo.
    Van Dyck K; Van Dijck P; Vande Velde G
    Methods Mol Biol; 2020; 2081():127-143. PubMed ID: 31721122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifungal activity against Candida biofilms.
    Iñigo M; Pemán J; Del Pozo JL
    Int J Artif Organs; 2012 Oct; 35(10):780-91. PubMed ID: 23138707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Candida biofilm-related infections].
    Del Pozo JL; Cantón E
    Rev Iberoam Micol; 2016; 33(3):176-83. PubMed ID: 27395021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Echinocandins in Candida Biofilm-Related Vascular Catheter Infections: In Vitro and In Vivo Model Systems.
    Ghannoum M; Roilides E; Katragkou A; Petraitis V; Walsh TJ
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S618-21. PubMed ID: 26567279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Candida biofilm drug resistance.
    Taff HT; Mitchell KF; Edward JA; Andes DR
    Future Microbiol; 2013 Oct; 8(10):1325-37. PubMed ID: 24059922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biofilm as a virulence marker in Candida species in Nosocomial blood stream infection and its correlation with antifungal resistance.
    Bhatt M; Sarangi G; Paty BP; Mohapatra D; Chayani N; Mahapatra A; Das P; Sahoo D
    Indian J Med Microbiol; 2015 Feb; 33 Suppl():112-4. PubMed ID: 25657126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination antifungals: an update.
    Segal BH; Steinbach WJ
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):883-92. PubMed ID: 17914921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biofilms and Antifungal Susceptibility Testing.
    Simitsopoulou M; Chatzimoschou A; Roilides E
    Methods Mol Biol; 2016; 1356():183-97. PubMed ID: 26519074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future directions for anti-biofilm therapeutics targeting Candida.
    Nett JE
    Expert Rev Anti Infect Ther; 2014 Mar; 12(3):375-82. PubMed ID: 24506174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin inhibits biofilm formation in Candida parapsilosis.
    Yang HP; Tsang PC; Tsang PW
    J Mycol Med; 2014 Dec; 24(4):360-1. PubMed ID: 25459679
    [No Abstract]   [Full Text] [Related]  

  • 17. Future therapies targeted towards eliminating Candida biofilms and associated infections.
    Bandara HM; Matsubara VH; Samaranayake LP
    Expert Rev Anti Infect Ther; 2017 Mar; 15(3):299-318. PubMed ID: 27927053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida biofilms: antifungal resistance and emerging therapeutic options.
    Kuhn DM; Ghannoum MA
    Curr Opin Investig Drugs; 2004 Feb; 5(2):186-97. PubMed ID: 15043393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miltefosine inhibits Candida albicans and non-albicans Candida spp. biofilms and impairs the dispersion of infectious cells.
    Vila T; Ishida K; Seabra SH; Rozental S
    Int J Antimicrob Agents; 2016 Nov; 48(5):512-520. PubMed ID: 27667564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Undressing the fungal cell wall/cell membrane--the antifungal drug targets.
    Tada R; Latgé JP; Aimanianda V
    Curr Pharm Des; 2013; 19(20):3738-47. PubMed ID: 23278542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.